Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
J Neurosurg. 2013 Sep;119(3):606-12. doi: 10.3171/2013.4.JNS121287. Epub 2013 May 31.
Data regarding the time course of recovery after poor-grade subarachnoid hemorrhage (SAH) is lacking. Most SAH studies assess outcome at a single time point, often as early as 3 or 6 months following SAH. The authors hypothesized that recovery following poor-grade SAH is a dynamic process and that early outcomes may not always approximate long-term outcomes. To test this hypothesis, they analyzed long-term outcome data from a cohort of patients with poor-grade aneurysmal SAH to determine the incidence and predictors of early and delayed neurological improvement.
The authors reviewed outcome data from 88 poor-grade SAH patients enrolled in a prospective SAH treatment trial (the Barrow Ruptured Aneurysm Trial). They assessed modified Rankin Scale (mRS) scores at discharge, 6 months, 12 months, and 36 months after treatment to determine the incidence and predictors of neurological improvement during each interval.
The mean aggregate mRS scores at 6 months (3.31 ± 2.1), 12 months (3.28 ± 2.2), and 36 months (3.17 ± 2.3) improved significantly compared with the mean score at hospital discharge (4.33 ± 1.3, p < 0.001), but they did not differ significantly among themselves. Between discharge and 6 months, 61% of patients improved on the mRS. The incidence of improvement between 6-12 months and 12-36 months was 18% and 19%, respectively. Hunt and Hess Grade IV versus V (OR 6.20, 95% CI 2.11-18.25, p < 0.001) and the absence of large (> 4 cm) (OR 2.76, 95% CI 1.02-7.55, p = 0.05) or eloquent (OR 5.17, 95% CI 1.89-14.10, p < 0.01) stroke were associated with improvement up to 6 months. Age ≤ 65 years (OR 5.56, 95% CI 1.17-26.42, p = 0.02), Hunt and Hess Grade IV versus V (OR 4.17, 95% CI 1.10-15.85, p = 0.03), and absence of a large (OR 8.97, 95% CI 2.65-30.40, p < 0.001) or eloquent (OR 4.54, 95% CI 1.46-14.08, p = 0.01) stroke were associated with improvement beyond 6 months. Improvement beyond 1 year was most strongly predicted by the absence of a large stroke (OR 7.62, 95% CI 1.55-37.30, p < 0.01).
A substantial minority of poor-grade SAH patients will experience delayed recovery beyond the point at which most studies assess outcome. Younger patients, those presenting in better clinical condition, and those without CT evidence of large or eloquent stroke demonstrated the highest capacity for delayed recovery.
缺乏关于蛛网膜下腔出血(SAH)后预后不良患者的恢复时间过程的数据。大多数 SAH 研究在单一时间点评估结果,通常在 SAH 后 3 或 6 个月。作者假设,预后不良的 SAH 患者的恢复是一个动态过程,早期结果并不总是接近长期结果。为了验证这一假设,他们分析了一项预后不良的动脉瘤性 SAH 患者队列的长期预后数据,以确定早期和迟发性神经改善的发生率和预测因素。
作者回顾了 88 名预后不良的 SAH 患者前瞻性 SAH 治疗试验(巴罗破裂动脉瘤试验)中的预后数据。他们在治疗后 6 个月、12 个月和 36 个月评估改良 Rankin 量表(mRS)评分,以确定每个时间段内神经改善的发生率和预测因素。
治疗后 6 个月(3.31 ± 2.1)、12 个月(3.28 ± 2.2)和 36 个月(3.17 ± 2.3)的平均综合 mRS 评分显著改善与出院时的平均评分(4.33 ± 1.3,p < 0.001)相比,但彼此之间没有显著差异。出院至 6 个月期间,61%的患者 mRS 评分有所改善。6-12 个月和 12-36 个月之间的改善发生率分别为 18%和 19%。Hunt 和 Hess 分级 IV 级与 V 级(OR 6.20,95%CI 2.11-18.25,p < 0.001)和无脑内大(> 4 cm)(OR 2.76,95%CI 1.02-7.55,p = 0.05)或重要功能区(OR 5.17,95%CI 1.89-14.10,p < 0.01)卒中与 6 个月内的改善相关。年龄≤65 岁(OR 5.56,95%CI 1.17-26.42,p = 0.02)、Hunt 和 Hess 分级 IV 级与 V 级(OR 4.17,95%CI 1.10-15.85,p = 0.03)和无脑内大(OR 8.97,95%CI 2.65-30.40,p < 0.001)或重要功能区(OR 4.54,95%CI 1.46-14.08,p = 0.01)卒中与 6 个月后的改善相关。大卒中的不存在(OR 7.62,95%CI 1.55-37.30,p < 0.01)与 1 年以上的改善最密切相关。
相当一部分预后不良的 SAH 患者在大多数研究评估结果的时间点之外会出现迟发性恢复。年轻患者、临床状况较好的患者以及无脑内大或重要功能区卒中的患者表现出最高的迟发性恢复能力。